Pharma giants pressure Trump admin to block Medicare drug price negotiations, maintaining high costs.

Big pharmaceutical companies are pressuring the Trump administration to loosen rules that allow Medicare to negotiate drug prices directly with them. This move aims to maintain current pricing strategies, which critics argue inflate costs for consumers.

November 27, 2024
5 Articles